An interventional study of Development of a screening algorithm designed to determine a "dysmobility" profile in patients with chronic illness. in Joint Osteoarthritis, Atherosclerosis of the Distal Arteries, Without Gangrene and Parkinson Disease, sponsored by University Hospital, Clermont-Ferrand. Recruiting at 1 site in France. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2025-05-28.
Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Diagnostic
Chronic illness is a public health issue and mobility loss is frequent in this population. Among its' multiple physical and psychological consequences, increased mortality and cardiovascular morbidity seem the main concern. Therefore, the exploration of locomotor deficiencies, physical capacities and metabolism of patients with chronic illnesses constitutes a major challenge both for the treatment of causal pathologies, as well as for evaluating the impact of therapeutic interventions, the benefit of which will be an improvement in physical capacities and ultimately mobility. In view of the hypothesis of an increase in the prevalence of mobility disorders in this population, this approach is part of a logic of screening and improving the effectiveness of the care of these patients with a multidisciplinary evaluation of individual risks. The EVALMOB protocol was designed in order to try to determine a standard profile of "dysmobility" in patients with chronic illness
We propose to constitute a prospective cohort of subjects carrying chronic disease. The objective is to explore all the different components of mobility (balance, muscle force, body composition, walking ability, metabolism, etc.), to assess their impact on the functional capacity of individuals and to identify their potential interactions. Processing this data could ultimately allow the development of a model to determine a composite standard profile of "dysmobility" in patients with chronic disease.
In the present protocol, parameters will be measured on five occasions (at inclusion, at 6 months from the inclusion day, at 1,2 and 5 year(s) from the inclusion day). All tests will be performed on the same day. New assessments will be done on the same principle as the initial evaluation.
Statistical analyses will be carried out using Stata software (version 13, StataCorp, College Station, USA). Data will be described by frequencies and percentages for categorical variables and by means and standard deviation (or median and interquartile range if data are not normally distributed) for continuous variables. The normality of continuous data will be assessed graphically and using the Shapiro-Wilk test. The main analysis will consist in determining patient profiles regarding their mobility. Clustering-type approaches (supervised or not) will be proposed: k-means, vector machine support, machine learning, factor analysis. For example, factor analyses on mixed data will allow the main components of mobility to be characterized. They can be followed by an ascending hierarchical classification in order to determine homogeneous groups of patients.
These groups will be described and compared on the main criteria evaluated using standard statistical tests: chi2 test (or Fisher's exact test if applicable) for the categorical criteria and using an analysis of variance (or Kruskal-Wallis if data are not normally distributed) for continuous criteria. The main analysis will be broken down more specifically for each of the pathologies considered. In addition, the sensitivity to change will be assessed in each pathology and for each assessment criterion. The search for factors related to the evolution of the different criteria will be carried out using usual tests and mixed multivariate models (logistics for categorical / linear criteria for continuous criteria) considering the subject as a random effect, and adjusting on the time criteria (inclusion / follow-up) and the criteria highlighted in the univariate analyses and in light of the elements reported in the literature. A sensitivity analysis will be proposed in order to study the statistical nature of the missing data and to propose, if necessary, the most suitable method of imputing the data: multiple imputation, maximum bias or LOCF in the case of longitudinal data.
Exclusion Criteria:
Participants will be involved in a long-term evaluation program combining, body composition measures, physical tests as well as self-administered questionnaires. Participants will be followed for 5 years with evaluations taking place at inclusion, 6 months, at 1, 2 and 5 years
Other: Development of a screening algorithm designed to determine a "dysmobility" profile in patients with chronic illness.
Firstly, volunteers will be invited to complete online questionnaires on a secure platform. The mobility assessment will be carried out initially (t1) and up to a maximum of 4 times (t1 to t4) as part of a day hospitalization. Questionnaires will be diverse (SF36, KOOS, HOOS, BROCKER, MNA, TAMPA, etc.) in order to assess several aspects that compose mobility. Physical evaluations will include various validated tests (isokinetic strength measure, TUG, 6MWT, Berg Balance Scale, etc.)
dismobility score calculated from the results reported in secondary outcomes
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles
Time frame: Day 0
dismobility score calculated from the results reported in secondary outcomes
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles
Time frame: Month 6
dismobility score calculated from the results reported in secondary outcomes
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles
Time frame: Year 1
dismobility score calculated from the results reported in secondary outcomes
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles
Time frame: Year 2
dismobility score calculated from the results reported in secondary outcomes
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles
Time frame: Year 5
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles
Demographics information will be obtained using a single questionnaire including questions on age, gender, qualification, personal work status, ethnicity, life and occupational events.
Time frame: Day 0
Weight (Kg).
Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations.
Time frame: Day 0
Weight (Kg).
Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations.
Time frame: Month 6
Weight (Kg).
Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations.
Time frame: Year 1
Weight (Kg).
Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations.
Time frame: Year 2
Weight (Kg).
Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations.
Time frame: Year 5
Height (cm).
Height will be measured with a wall mounted tape measure and according to the ISAK recommendations
Time frame: Day 0
Height (cm).
Height will be measured with a wall mounted tape measure and according to the ISAK recommendations
Time frame: Month 6
Height (cm).
Height will be measured with a wall mounted tape measure and according to the ISAK recommendations
Time frame: Year 1
Height (cm).
Height will be measured with a wall mounted tape measure and according to the ISAK recommendations
Time frame: Year 2
Height (cm).
Height will be measured with a wall mounted tape measure and according to the ISAK recommendations
Time frame: Year 5
Body fat percentage (%).
Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular).
Time frame: Day 0
Body fat percentage (%).
Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular).
Time frame: Month 6
Body fat percentage (%).
Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular).
Time frame: Year 1
Body fat percentage (%).
Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular).
Time frame: Year 2
Body fat percentage (%).
Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular).
Time frame: Year 5
Waist circumference (cm).
Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations
Time frame: Day 0
Waist circumference (cm).
Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations
Time frame: Month 5
Waist circumference (cm).
Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations
Time frame: Year 1
Waist circumference (cm).
Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations
Time frame: Year 2
Waist circumference (cm).
Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations
Time frame: Year 5
Hip circumference (cm).
Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations.
Time frame: Day 0
Hip circumference (cm).
Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations.
Time frame: Month 6
Hip circumference (cm).
Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations.
Time frame: Year 1
Hip circumference (cm).
Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations.
Time frame: Year 2
Hip circumference (cm).
Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations.
Time frame: Year 5
Brachial circumference (cm).
Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations.
Time frame: Day 0
Brachial circumference (cm).
Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations.
Time frame: Month 6
Brachial circumference (cm).
Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations.
Time frame: Year 1
Brachial circumference (cm).
Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations.
Time frame: Year 2
Brachial circumference (cm).
Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations.
Time frame: Year 5
Calf circumference (cm).
Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations
Time frame: Day 0
Calf circumference (cm).
Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations
Time frame: Month 6
Calf circumference (cm).
Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations
Time frame: Year 1
Calf circumference (cm).
Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations
Time frame: Year 2
Calf circumference (cm).
Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations
Time frame: Year 5
Body Mass Index (Kg/m²).
BMI will be calculated (weight in kilograms divided by height in meters squared).
Time frame: Day 0
Body Mass Index (Kg/m²).
BMI will be calculated (weight in kilograms divided by height in meters squared).
Time frame: Month 6
Body Mass Index (Kg/m²).
BMI will be calculated (weight in kilograms divided by height in meters squared).
Time frame: Year 1
Body Mass Index (Kg/m²).
BMI will be calculated (weight in kilograms divided by height in meters squared).
Time frame: Year 2
Body Mass Index (Kg/m²).
BMI will be calculated (weight in kilograms divided by height in meters squared).
Time frame: Year 5
Body composition
Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter.
Time frame: Day 0
Body composition
Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter.
Time frame: Month 6
Body composition
Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter.
Time frame: Year 1
Body composition
Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter.
Time frame: Year 2
Body composition
Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter.
Time frame: Year 5
T-score (DS).
- Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: DAy 0
T-score (DS).
- Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Month 6
T-score (DS).
- Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 1
T-score (DS).
- Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 2
T-score (DS).
- Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 5
Z-score (DS).
Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer
Time frame: Day 0
Z-score (DS).
Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer
Time frame: Month 6
Z-score (DS).
Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer
Time frame: Year 1
Z-score (DS).
Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer
Time frame: Year 2
Z-score (DS).
Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer
Time frame: Year 5
Fat mass
Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Day 0
Fat mass
Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Month 6
Fat mass
Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 1
Fat mass
Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 2
Fat mass
Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 5
Fat-free mass (%).
: Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Day 0
Fat-free mass (%).
: Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Month 6
Fat-free mass (%).
: Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 1
Fat-free mass (%).
: Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 2
Fat-free mass (%).
: Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 5
Fat mas index (Kg/m²).
Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Day 0
Fat mas index (Kg/m²).
Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Month 6
Fat mas index (Kg/m²).
Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 1
Fat mas index (Kg/m²).
Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 2
Fat mas index (Kg/m²).
Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 5
Ratio of android to gynoid fat mass.
Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer
Time frame: Day 0
Ratio of android to gynoid fat mass.
Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer
Time frame: Month 6
Ratio of android to gynoid fat mass.
Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer
Time frame: Year 1
Ratio of android to gynoid fat mass.
Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer
Time frame: Year 2
Ratio of android to gynoid fat mass.
Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer
Time frame: Year 5
Visceral adipose tissue (Kg).
Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Day 0
Visceral adipose tissue (Kg).
Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Month 6
Visceral adipose tissue (Kg).
Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 1
Visceral adipose tissue (Kg).
Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 2
Visceral adipose tissue (Kg).
Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 5
Fat-free mass index (kg/m²).
: Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Day 0
Fat-free mass index (kg/m²).
: Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Month 6
Fat-free mass index (kg/m²).
: Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 1
Fat-free mass index (kg/m²).
: Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 2
Fat-free mass index (kg/m²).
: Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 5
Appendicular fat-free mass index (Kg/m²).
Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Day 0
Appendicular fat-free mass index (Kg/m²).
Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Month 6
Appendicular fat-free mass index (Kg/m²).
Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 1
Appendicular fat-free mass index (Kg/m²).
Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 2
Appendicular fat-free mass index (Kg/m²).
Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 5
Bone mass (Kg)
- Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Day 0
Bone mass (Kg)
- Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Month 6
Bone mass (Kg)
- Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 1
Bone mass (Kg)
- Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 2
Bone mass (Kg)
- Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer.
Time frame: Year 5
Daily caloric intake (Kcal/24h).
Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Day 0
Daily caloric intake (Kcal/24h).
Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Month 6
Daily caloric intake (Kcal/24h).
Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Year 1
Daily caloric intake (Kcal/24h).
Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Year 2
Daily caloric intake (Kcal/24h).
Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Year 5
Daily protein intake (in g and as a percentage of total caloric intake).
Daily protein intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Day 0
Daily protein intake (in g and as a percentage of total caloric intake).
Daily protein intake (in g and as a percentage of total caloric intake).
Time frame: Month 6
Daily protein intake (in g and as a percentage of total caloric intake).
Daily protein intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Year 1
Daily protein intake (in g and as a percentage of total caloric intake).
Daily protein intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Year 2
Daily protein intake (in g and as a percentage of total caloric intake).
Daily protein intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Year 5
Daily carbohydrate intake (in g and as a percentage of total caloric intake).
Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Day 0
Daily carbohydrate intake (in g and as a percentage of total caloric intake).
Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Month 6
Daily carbohydrate intake (in g and as a percentage of total caloric intake).
Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Year 1
Daily carbohydrate intake (in g and as a percentage of total caloric intake).
Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Year 2
Daily carbohydrate intake (in g and as a percentage of total caloric intake).
Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Year 5
Daily fat intake (in g and as a percentage of total caloric intake).
Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Day 0
Daily fat intake (in g and as a percentage of total caloric intake).
Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Month 6
Daily fat intake (in g and as a percentage of total caloric intake).
Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Year 1
Daily fat intake (in g and as a percentage of total caloric intake).
Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Year 2
Daily fat intake (in g and as a percentage of total caloric intake).
Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours).
Time frame: Year 5
Nutritional status assessment
Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire.
Time frame: Day 0
Nutritional status assessment
Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire.
Time frame: Month 6
Nutritional status assessment
Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire.
Time frame: Year 1
Nutritional status assessment
Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire.
Time frame: Year 2
Nutritional status assessment
Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire.
Time frame: Year 5
Risk of undernutrition.
Risk of undernutrition will be assessed with the Brocker Questionnaire
Time frame: Day 0
Risk of undernutrition.
Risk of undernutrition will be assessed with the Brocker Questionnaire
Time frame: Month 6
Risk of undernutrition.
Risk of undernutrition will be assessed with the Brocker Questionnaire
Time frame: Year 1
Risk of undernutrition.
Risk of undernutrition will be assessed with the Brocker Questionnaire
Time frame: Year 2
Risk of undernutrition.
Risk of undernutrition will be assessed with the Brocker Questionnaire
Time frame: Year 5
Basic biology.
: Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK)
Time frame: Day 0
Basic biology.
: Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK)
Time frame: Month 6
Basic biology.
: Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK)
Time frame: Year 1
Basic biology.
: Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK)
Time frame: Year 2
Basic biology.
: Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK)
Time frame: Year 5
Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm).
: Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device.
Time frame: Day 0
Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm).
: Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device.
Time frame: Month 6
Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm).
: Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device.
Time frame: Year 1
Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm).
: Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device.
Time frame: Year 2
Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm).
: Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device.
Time frame: Year 5
Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm).
- Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device.
Time frame: Day 0
Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm).
- Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device.
Time frame: Month 6
Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm).
- Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device.
Time frame: Year 1
Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm).
- Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device.
Time frame: Year 2
Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm).
- Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device.
Time frame: Year 5
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm).
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device.
Time frame: Day 0
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm).
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device.
Time frame: Month 6
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm).
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device.
Time frame: Year 1
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm).
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device.
Time frame: Year 2
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm).
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device.
Time frame: Year 5
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm).
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device.
Time frame: Day 0
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm).
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device.
Time frame: Month 6
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm).
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device.
Time frame: Year 1
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm).
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device.
Time frame: Year 2
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm).
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device.
Time frame: Year 5
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm).
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device.
Time frame: Day 0
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm).
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device.
Time frame: Month 6
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm).
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device.
Time frame: Year 1
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm).
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device.
Time frame: Year 2
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm).
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device.
Time frame: Year 5
Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm).
- Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device.
Time frame: Day 0
Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm).
- Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device.
Time frame: Month 6
Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm).
- Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device.
Time frame: Year 1
Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm).
- Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device.
Time frame: Year 2
Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm).
- Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device.
Time frame: Year 5
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm).
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device.
Time frame: Day 0
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm).
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device.
Time frame: Month 6
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm).
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device.
Time frame: Year 1
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm).
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device.
Time frame: Year 2
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm).
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device.
Time frame: Year 5
Endurance coefficient of the quadriceps muscles at 180°/s.
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.
Time frame: Day 0
Endurance coefficient of the quadriceps muscles at 180°/s.
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.
Time frame: Month 6
Endurance coefficient of the quadriceps muscles at 180°/s.
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.
Time frame: Year 1
Endurance coefficient of the quadriceps muscles at 180°/s.
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.
Time frame: Year 2
Endurance coefficient of the quadriceps muscles at 180°/s.
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.
Time frame: Year 5
Endurance coefficient of the hamstring muscles at 180°/s.
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device..
Time frame: Day 0
Endurance coefficient of the hamstring muscles at 180°/s.
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device..
Time frame: Month 6
Endurance coefficient of the hamstring muscles at 180°/s.
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device..
Time frame: Year 1
Endurance coefficient of the hamstring muscles at 180°/s.
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device..
Time frame: Year 2
Endurance coefficient of the hamstring muscles at 180°/s.
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device..
Time frame: Year 5
Functional ratio
Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s.
Time frame: Day 0
Functional ratio
Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s.
Time frame: Month 6
Functional ratio
Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s.
Time frame: Year 1
Functional ratio
Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s.
Time frame: Year 2
Functional ratio
Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s.
Time frame: Year 5
Mixed ratio
- Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s.
Time frame: Day 0
Mixed ratio
- Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s.
Time frame: Month 6
Mixed ratio
- Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s.
Time frame: Year 1
Mixed ratio
- Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s.
Time frame: Year 2
Mixed ratio
- Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s.
Time frame: Year 5
Maximum voluntary hand grip strength (Kg).
Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer.
Time frame: Day 0
Maximum voluntary hand grip strength (Kg).
Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer.
Time frame: Month 6
Maximum voluntary hand grip strength (Kg).
Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer.
Time frame: Year 1
Maximum voluntary hand grip strength (Kg).
Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer.
Time frame: Year 2
Maximum voluntary hand grip strength (Kg).
Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer.
Time frame: Year 5
Maximum voluntary pinch strength (Kg).
Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer.
Time frame: Day 0
Maximum voluntary pinch strength (Kg).
Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer.
Time frame: Month 6
Maximum voluntary pinch strength (Kg).
Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer.
Time frame: Year 1
Maximum voluntary pinch strength (Kg).
Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer.
Time frame: Year 2
Maximum voluntary pinch strength (Kg).
Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer.
Time frame: Year 5
Hip passive joint range
Hip joint range will be measured with a medical goniometer.
Time frame: Day 0
Hip passive joint range
Hip joint range will be measured with a medical goniometer.
Time frame: Month 6
Hip passive joint range
Hip joint range will be measured with a medical goniometer.
Time frame: Year 1
Hip passive joint range
Hip joint range will be measured with a medical goniometer.
Time frame: Year 2
Hip passive joint range
Hip joint range will be measured with a medical goniometer.
Time frame: Year 5
Knee passive joint range.
Knee joint range will be measured with a medical goniometer.
Time frame: Day 0
Knee passive joint range.
Knee joint range will be measured with a medical goniometer.
Time frame: Month 6
Knee passive joint range.
Knee joint range will be measured with a medical goniometer.
Time frame: Year 1
Knee passive joint range.
Knee joint range will be measured with a medical goniometer.
Time frame: Year 2
Knee passive joint range.
Knee joint range will be measured with a medical goniometer.
Time frame: Year 5
Ankle passive joint range
Ankle joint range will be measured with a medical goniometer.
Time frame: Day 0
Ankle passive joint range
Ankle joint range will be measured with a medical goniometer.
Time frame: Month 6
Ankle passive joint range
Ankle joint range will be measured with a medical goniometer.
Time frame: Year 1
Ankle passive joint range
Ankle joint range will be measured with a medical goniometer.
Time frame: Year 2
Ankle passive joint range
Ankle joint range will be measured with a medical goniometer.
Time frame: Year 5
Lower and upper limb muscle power assessment (MRC)
Lower and upper limb muscle power assessment will be performed by an experienced physician.
Time frame: Day 0
Lower and upper limb muscle power assessment (MRC)
Lower and upper limb muscle power assessment will be performed by an experienced physician.
Time frame: Month 6
Lower and upper limb muscle power assessment (MRC)
Lower and upper limb muscle power assessment will be performed by an experienced physician.
Time frame: Year 1
Lower and upper limb muscle power assessment (MRC)
Lower and upper limb muscle power assessment will be performed by an experienced physician.
Time frame: Year 2
Lower and upper limb muscle power assessment (MRC)
Lower and upper limb muscle power assessment will be performed by an experienced physician.
Time frame: Year 5
Statokinesigram surface area (mm²)
Statokinesigram surface area will be measured with the STATIPRO® static posturography platform.
Time frame: Day 0
Statokinesigram surface area (mm²)
Statokinesigram surface area will be measured with the STATIPRO® static posturography platform.
Time frame: Month 6
Statokinesigram surface area (mm²)
Statokinesigram surface area will be measured with the STATIPRO® static posturography platform.
Time frame: Year 1
Statokinesigram surface area (mm²)
Statokinesigram surface area will be measured with the STATIPRO® static posturography platform.
Time frame: Year 2
Statokinesigram surface area (mm²)
Statokinesigram surface area will be measured with the STATIPRO® static posturography platform.
Time frame: Year 5
Stabilogram length (mm).
Stabilogram length will be measured with the STATIPRO® static posturography platform
Time frame: Day 0
Stabilogram length (mm).
Stabilogram length will be measured with the STATIPRO® static posturography platform
Time frame: Month 6
Stabilogram length (mm).
Stabilogram length will be measured with the STATIPRO® static posturography platform
Time frame: Year 1
Stabilogram length (mm).
Stabilogram length will be measured with the STATIPRO® static posturography platform
Time frame: Year 2
Stabilogram length (mm).
Stabilogram length will be measured with the STATIPRO® static posturography platform
Time frame: Year 5
Maximal deflection (forward, backward left and right).
Maximal deflection will be measured with the STATIPRO® static posturography platform.
Time frame: Day 0
Maximal deflection (forward, backward left and right).
Maximal deflection will be measured with the STATIPRO® static posturography platform.
Time frame: Month 6
Maximal deflection (forward, backward left and right).
Maximal deflection will be measured with the STATIPRO® static posturography platform.
Time frame: Year 1
Maximal deflection (forward, backward left and right).
Maximal deflection will be measured with the STATIPRO® static posturography platform.
Time frame: Year 2
Maximal deflection (forward, backward left and right).
Maximal deflection will be measured with the STATIPRO® static posturography platform.
Time frame: Year 5
Velocity variations (mm/s).
: Velocity variations will be measured with the STATIPRO® static posturography platform.
Time frame: Day 0
Velocity variations (mm/s).
: Velocity variations will be measured with the STATIPRO® static posturography platform.
Time frame: Month 6
Velocity variations (mm/s).
: Velocity variations will be measured with the STATIPRO® static posturography platform.
Time frame: Year 1
Velocity variations (mm/s).
: Velocity variations will be measured with the STATIPRO® static posturography platform.
Time frame: Year 2
Velocity variations (mm/s).
: Velocity variations will be measured with the STATIPRO® static posturography platform.
Time frame: Year 5
: Romberg ratio according to sway area
Romberg ratio will be measured with the STATIPRO® static posturography platform.
Time frame: Day 0
: Romberg ratio according to sway area
Romberg ratio will be measured with the STATIPRO® static posturography platform.
Time frame: Month 6
: Romberg ratio according to sway area
Romberg ratio will be measured with the STATIPRO® static posturography platform.
Time frame: Year 1
: Romberg ratio according to sway area
Romberg ratio will be measured with the STATIPRO® static posturography platform.
Time frame: Year 2
: Romberg ratio according to sway area
Romberg ratio will be measured with the STATIPRO® static posturography platform.
Time frame: Year 5
Romberg ratio according to center of pressure path length
Romberg ratio will be measured with the STATIPRO® static posturography platform.
Time frame: Day 0
Romberg ratio according to center of pressure path length
Romberg ratio will be measured with the STATIPRO® static posturography platform.
Time frame: Month 6
Romberg ratio according to center of pressure path length
Romberg ratio will be measured with the STATIPRO® static posturography platform.
Time frame: Year 1
Romberg ratio according to center of pressure path length
Romberg ratio will be measured with the STATIPRO® static posturography platform.
Time frame: Year 2
Romberg ratio according to center of pressure path length
Romberg ratio will be measured with the STATIPRO® static posturography platform.
Time frame: Year 5
: Plantar pressure ratio sway area.
Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform.
Time frame: Day 0
: Plantar pressure ratio sway area.
Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform.
Time frame: Month 6
: Plantar pressure ratio sway area.
Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform.
Time frame: Year 1
: Plantar pressure ratio sway area.
Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform.
Time frame: Year 2
: Plantar pressure ratio sway area.
Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform.
Time frame: Year 5
Plantar pressure ratio length.
Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform.
Time frame: Day 0
Plantar pressure ratio length.
Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform.
Time frame: Month 6
Plantar pressure ratio length.
Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform.
Time frame: Year 1
Plantar pressure ratio length.
Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform.
Time frame: Year 2
Plantar pressure ratio length.
Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform.
Time frame: Year 5
Walking velocity (cm/s).
Walking velocity will be measured with the GAITRite® Electronic Walkway.
Time frame: Day 0
Walking velocity (cm/s).
Walking velocity will be measured with the GAITRite® Electronic Walkway.
Time frame: Month 6
Walking velocity (cm/s).
Walking velocity will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 1
Walking velocity (cm/s).
Walking velocity will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 2
Walking velocity (cm/s).
Walking velocity will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 5
Cadence (steps/min).
: Cadence will be measured with the GAITRite® Electronic Walkway.
Time frame: Day 0
Cadence (steps/min).
: Cadence will be measured with the GAITRite® Electronic Walkway.
Time frame: Month 6
Cadence (steps/min).
: Cadence will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 1
Cadence (steps/min).
: Cadence will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 2
Cadence (steps/min).
: Cadence will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 5
Step length (left and right foot) (cm)
Step length will be measured with the GAITRite® Electronic Walkway.
Time frame: DAy 0
Step length (left and right foot) (cm)
Step length will be measured with the GAITRite® Electronic Walkway.
Time frame: Month 6
Step length (left and right foot) (cm)
Step length will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 1
Step length (left and right foot) (cm)
Step length will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 2
Step length (left and right foot) (cm)
Step length will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 5
Stride length (cm).
Stride length will be measured with the GAITRite® Electronic Walkway.
Time frame: Day 0
Stride length (cm).
Stride length will be measured with the GAITRite® Electronic Walkway.
Time frame: month 6
Stride length (cm).
Stride length will be measured with the GAITRite® Electronic Walkway.
Time frame: year 1
Stride length (cm).
Stride length will be measured with the GAITRite® Electronic Walkway.
Time frame: year 2
Stride length (cm).
Stride length will be measured with the GAITRite® Electronic Walkway.
Time frame: year 5
Single support time left and right foot (s).
Single support time will be measured with the GAITRite® Electronic Walkway.
Time frame: Day 0
Single support time left and right foot (s).
Single support time will be measured with the GAITRite® Electronic Walkway.
Time frame: Month 6
Single support time left and right foot (s).
Single support time will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 1
Single support time left and right foot (s).
Single support time will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 2
Single support time left and right foot (s).
Single support time will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 5
Double support time (s).
: Double support time will be measured with the GAITRite® Electronic Walkway.
Time frame: Day 0
Double support time (s).
: Double support time will be measured with the GAITRite® Electronic Walkway.
Time frame: Month 6
Double support time (s).
: Double support time will be measured with the GAITRite® Electronic Walkway.
Time frame: YEar 1
Double support time (s).
: Double support time will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 2
Double support time (s).
: Double support time will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 5
Swing time (s).
: Swing time will be measured with the GAITRite® Electronic Walkway.
Time frame: Day 0
Swing time (s).
: Swing time will be measured with the GAITRite® Electronic Walkway.
Time frame: Month 6
Swing time (s).
: Swing time will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 1
Swing time (s).
: Swing time will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 2
Swing time (s).
: Swing time will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 5
Swing phase (as a % of walking cycle).
: Swing phase will be measured with the GAITRite® Electronic Walkway.
Time frame: DAy 0
Swing phase (as a % of walking cycle).
: Swing phase will be measured with the GAITRite® Electronic Walkway.
Time frame: Month 6
Swing phase (as a % of walking cycle).
: Swing phase will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 1
Swing phase (as a % of walking cycle).
: Swing phase will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 2
Swing phase (as a % of walking cycle).
: Swing phase will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 5
Stance phase (as a % of walking cycle).
Stance phase will be measured with the GAITRite® Electronic Walkway.
Time frame: Day 0
Stance phase (as a % of walking cycle).
Stance phase will be measured with the GAITRite® Electronic Walkway.
Time frame: Month 6
Stance phase (as a % of walking cycle).
Stance phase will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 1
Stance phase (as a % of walking cycle).
Stance phase will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 2
Stance phase (as a % of walking cycle).
Stance phase will be measured with the GAITRite® Electronic Walkway.
Time frame: Year 5
Vo2max (maximal oxygen consumption) (mL/Kg/min).
: Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Day 0
Vo2max (maximal oxygen consumption) (mL/Kg/min).
: Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Month 6
Vo2max (maximal oxygen consumption) (mL/Kg/min).
: Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Year 1
Vo2max (maximal oxygen consumption) (mL/Kg/min).
: Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Year 2
Vo2max (maximal oxygen consumption) (mL/Kg/min).
: Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Year 5
Maximum heart rate (bpm).
Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Day 0
Maximum heart rate (bpm).
Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Month 6
Maximum heart rate (bpm).
Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Year 1
Maximum heart rate (bpm).
Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Year 2
Maximum heart rate (bpm).
Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Year 5
Maximum power (Watts).
Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Day 0
Maximum power (Watts).
Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Month 6
Maximum power (Watts).
Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Year 1
Maximum power (Watts).
Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Year 2
Maximum power (Watts).
Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Year 5
Threshold power (Watts).
Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Day 0
Threshold power (Watts).
Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Month 6
Threshold power (Watts).
Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Year 1
Threshold power (Watts).
Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Year 2
Threshold power (Watts).
Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Year 5
Threshold heart rate (bpm).
Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: DAy 0
Threshold heart rate (bpm).
Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Month 6
Threshold heart rate (bpm).
Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Year 1
Threshold heart rate (bpm).
Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Year 2
Threshold heart rate (bpm).
Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Year 5
Forced vital Capacity (L).
: Forced vital Capacity will be measured with a spirometry test.
Time frame: Day 0
Forced vital Capacity (L).
: Forced vital Capacity will be measured with a spirometry test.
Time frame: Month 6
Forced vital Capacity (L).
: Forced vital Capacity will be measured with a spirometry test.
Time frame: Year 1
Forced vital Capacity (L).
: Forced vital Capacity will be measured with a spirometry test.
Time frame: Year 2
Forced vital Capacity (L).
: Forced vital Capacity will be measured with a spirometry test.
Time frame: Year 5
Forced Expiratory volume (L)
Forced Expiratory volume will be measured with a spirometry test.
Time frame: Day 0
Forced Expiratory volume (L)
Forced Expiratory volume will be measured with a spirometry test.
Time frame: Month 6
Forced Expiratory volume (L)
Forced Expiratory volume will be measured with a spirometry test.
Time frame: Year 1
Forced Expiratory volume (L)
Forced Expiratory volume will be measured with a spirometry test.
Time frame: Year 2
Forced Expiratory volume (L)
Forced Expiratory volume will be measured with a spirometry test.
Time frame: Year 5
Tiffeneau ratio (%).
Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity.
Time frame: Day 0
Tiffeneau ratio (%).
Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity.
Time frame: Month 6
Tiffeneau ratio (%).
Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity.
Time frame: Year 1
Tiffeneau ratio (%).
Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity.
Time frame: Year 2
Tiffeneau ratio (%).
Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity.
Time frame: Year 5
Ventilatory reserve (%).
Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Day 0
Ventilatory reserve (%).
Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Month 6
Ventilatory reserve (%).
Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Year 1
Ventilatory reserve (%).
Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Year 2
Ventilatory reserve (%).
Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer.
Time frame: Year 5
Physical activity
Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ)
Time frame: Day 0
Physical activity
Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ)
Time frame: Month 6
Physical activity
Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ)
Time frame: Year 1
Physical activity
Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ)
Time frame: Year 2
Physical activity
Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ)
Time frame: Year 5
Functional capacity timed-up and go
Functional capacity will be evaluated using the Timed-Up and Go test.
Time frame: Day 0
Functional capacity timed-up and go
Functional capacity will be evaluated using the Timed-Up and Go test.
Time frame: Month 6
Functional capacity timed-up and go
Functional capacity will be evaluated using the Timed-Up and Go test.
Time frame: Year 1
Functional capacity timed-up and go
Functional capacity will be evaluated using the Timed-Up and Go test.
Time frame: Year 2
Functional capacity timed-up and go
Functional capacity will be evaluated using the Timed-Up and Go test.
Time frame: Year 5
Functional capacity TDM6
Functional capacity will be evaluated using the 6-minute walk test.
Time frame: Day 0
Functional capacity TDM6
Functional capacity will be evaluated using the 6-minute walk test.
Time frame: Month 6
Functional capacity TDM6
Functional capacity will be evaluated using the 6-minute walk test.
Time frame: Year 1
Functional capacity TDM6
Functional capacity will be evaluated using the 6-minute walk test.
Time frame: Year 2
Functional capacity TDM6
Functional capacity will be evaluated using the 6-minute walk test.
Time frame: Year 5
Functional capacity Five Times Sit to Stand test.
Functional capacity will be evaluated using the Five Times Sit to Stand test.
Time frame: Day 0
Functional capacity Five Times Sit to Stand test.
Functional capacity will be evaluated using the Five Times Sit to Stand test.
Time frame: Month 6
Functional capacity Five Times Sit to Stand test.
Functional capacity will be evaluated using the Five Times Sit to Stand test.
Time frame: Year 1
Functional capacity Five Times Sit to Stand test.
Functional capacity will be evaluated using the Five Times Sit to Stand test.
Time frame: Year 2
Functional capacity Five Times Sit to Stand test.
Functional capacity will be evaluated using the Five Times Sit to Stand test.
Time frame: Year 5
Functional capacity SPPB
Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test.
Time frame: Day 0
Functional capacity SPPB
Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test.
Time frame: Month 6
Functional capacity SPPB
Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test.
Time frame: Year 1
Functional capacity SPPB
Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test.
Time frame: Year 2
Functional capacity SPPB
Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test.
Time frame: Year 5
Functional capacity the mini-BESTest.
Functional capacity will be evaluated using the mini-BESTest.
Time frame: Day 0
Functional capacity the mini-BESTest.
Functional capacity will be evaluated using the mini-BESTest.
Time frame: Month 6
Functional capacity the mini-BESTest.
Functional capacity will be evaluated using the mini-BESTest.
Time frame: Year 1
Functional capacity the mini-BESTest.
Functional capacity will be evaluated using the mini-BESTest.
Time frame: Year 2
Functional capacity the mini-BESTest.
Functional capacity will be evaluated using the mini-BESTest.
Time frame: Year 5
Functional capacity Berg Balance Scale.
Functional capacity will be evaluated using the Berg Balance Scale.
Time frame: Day 0
Functional capacity Berg Balance Scale.
Functional capacity will be evaluated using the Berg Balance Scale.
Time frame: Month 6
Functional capacity Berg Balance Scale.
Functional capacity will be evaluated using the Berg Balance Scale.
Time frame: Year 1
Functional capacity Berg Balance Scale.
Functional capacity will be evaluated using the Berg Balance Scale.
Time frame: Year 2
Functional capacity Berg Balance Scale.
Functional capacity will be evaluated using the Berg Balance Scale.
Time frame: Year 5
Functional capacity 10-meter walk test
Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace).
Time frame: Day 0
Functional capacity 10-meter walk test
Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace).
Time frame: Month 6
Functional capacity 10-meter walk test
Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace).
Time frame: Year 1
Functional capacity 10-meter walk test
Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace).
Time frame: Year 2
Functional capacity 10-meter walk test
Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace).
Time frame: Year 5
Dyspnea
Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10.
Time frame: Day 0
Dyspnea
Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10.
Time frame: Month 6
Dyspnea
Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10.
Time frame: Year 1
Dyspnea
Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10.
Time frame: Year 2
Dyspnea
Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10.
Time frame: Year 5
Perceived exertion before, during and after effort
Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10.
Time frame: DAy 0
Perceived exertion before, during and after effort
Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10.
Time frame: Month 6
Perceived exertion before, during and after effort
Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10.
Time frame: Year 1
Perceived exertion before, during and after effort
Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10.
Time frame: Year 2
Perceived exertion before, during and after effort
Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10.
Time frame: Year 5
Pain
: Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales.
Time frame: Day 0
Pain
: Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales.
Time frame: Month 6
Pain
: Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales.
Time frame: Year 1
Pain
: Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales.
Time frame: Year 2
Pain
: Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales.
Time frame: Year 5
Sarcopenia risk
Sarcopenia risk will be evaluated with the SARC-F Questionnaire.
Time frame: Day 0
Sarcopenia risk
Sarcopenia risk will be evaluated with the SARC-F Questionnaire.
Time frame: Month 6
Sarcopenia risk
Sarcopenia risk will be evaluated with the SARC-F Questionnaire.
Time frame: Year 1
Sarcopenia risk
Sarcopenia risk will be evaluated with the SARC-F Questionnaire.
Time frame: Year 2
Sarcopenia risk
Sarcopenia risk will be evaluated with the SARC-F Questionnaire.
Time frame: Year 5
Social insecurity
Social insecurity will be evaluated with the EPICES Score Questionnaire.
Time frame: Day 0
Social insecurity
Social insecurity will be evaluated with the EPICES Score Questionnaire.
Time frame: Month 6
Social insecurity
Social insecurity will be evaluated with the EPICES Score Questionnaire.
Time frame: Year 1
Social insecurity
Social insecurity will be evaluated with the EPICES Score Questionnaire.
Time frame: Year 2
Social insecurity
Social insecurity will be evaluated with the EPICES Score Questionnaire.
Time frame: Year 5
Kinesiophobia
Kinesiophobia will be evaluated with the TAMPA Scale.
Time frame: Day 0
Kinesiophobia
Kinesiophobia will be evaluated with the TAMPA Scale.
Time frame: Month 6
Kinesiophobia
Kinesiophobia will be evaluated with the TAMPA Scale.
Time frame: Year 1
Kinesiophobia
Kinesiophobia will be evaluated with the TAMPA Scale.
Time frame: Year 2
Kinesiophobia
Kinesiophobia will be evaluated with the TAMPA Scale.
Time frame: Year 5
Quality of life
Quality of life will be evaluated with the 36-Item Short Form Survey.
Time frame: Day 0
Quality of life
Quality of life will be evaluated with the 36-Item Short Form Survey.
Time frame: Month 6
Quality of life
Quality of life will be evaluated with the 36-Item Short Form Survey.
Time frame: Year 1
Quality of life
Quality of life will be evaluated with the 36-Item Short Form Survey.
Time frame: Year 2
Quality of life
Quality of life will be evaluated with the 36-Item Short Form Survey.
Time frame: Year 5
: Balance confidence in performing various activities
Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey.
Time frame: Day 0
: Balance confidence in performing various activities
Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey.
Time frame: Month 6
: Balance confidence in performing various activities
Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey.
Time frame: Year 1
: Balance confidence in performing various activities
Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey.
Time frame: Year 2
: Balance confidence in performing various activities
Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey.
Time frame: Year 5
Functioning in regards to activities of daily living.
Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale.
Time frame: Day 0
Functioning in regards to activities of daily living.
Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale.
Time frame: Month 6
Functioning in regards to activities of daily living.
Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale.
Time frame: Year 1
Functioning in regards to activities of daily living.
Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale.
Time frame: Year 2
Functioning in regards to activities of daily living.
Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale.
Time frame: Year 5
Exhaustion
Exhaustion will be evaluated with the FACIT-F Questionnaire.
Time frame: Day 0
Exhaustion
Exhaustion will be evaluated with the FACIT-F Questionnaire.
Time frame: Month 6
Exhaustion
Exhaustion will be evaluated with the FACIT-F Questionnaire.
Time frame: Year 1
Exhaustion
Exhaustion will be evaluated with the FACIT-F Questionnaire.
Time frame: Year 2
Exhaustion
Exhaustion will be evaluated with the FACIT-F Questionnaire.
Time frame: Year 5
Patient's opinion about their knee and associated problems
: Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS).
Time frame: Day 0
Patient's opinion about their knee and associated problems
: Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS).
Time frame: Month 6
Patient's opinion about their knee and associated problems
: Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS).
Time frame: Year 1
Patient's opinion about their knee and associated problems
: Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS).
Time frame: Year 2
Patient's opinion about their knee and associated problems
: Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS).
Time frame: Year 5
Patient's opinion about their hip and associated problems
Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS).
Time frame: Day 0
Patient's opinion about their hip and associated problems
Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS).
Time frame: Month 6
Patient's opinion about their hip and associated problems
Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS).
Time frame: Year 1
Patient's opinion about their hip and associated problems
Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS).
Time frame: Year 2
Patient's opinion about their hip and associated problems
Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS).
Time frame: Year 5
Predicting discharge destination after total joint arthroplasty.
: Discharge destination will be evaluated with the Risk Assessment and Prediction Tool (RAPT);
Time frame: Day 0
Predicting discharge destination after total joint arthroplasty.
: Discharge destination will be evaluated with the Risk Assessment and Prediction Tool (RAPT);
Time frame: Month 6
Physical function in myositis patients
Physical function will be evaluated with the Stanford Health Assessment Questionnaire.
Time frame: Day 0
Physical function in myositis patients
Physical function will be evaluated with the Stanford Health Assessment Questionnaire.
Time frame: Month 6
Physical function in myositis patients
Physical function will be evaluated with the Stanford Health Assessment Questionnaire.
Time frame: Year 1
Physical function in myositis patients
Physical function will be evaluated with the Stanford Health Assessment Questionnaire.
Time frame: Year 2
Physical function in myositis patients
Physical function will be evaluated with the Stanford Health Assessment Questionnaire.
Time frame: Year 5
Quality of life in Parkinson's Disease
Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39).
Time frame: Day 0
Quality of life in Parkinson's Disease
Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39).
Time frame: Month 6
Quality of life in Parkinson's Disease
Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39).
Time frame: Year 1
Quality of life in Parkinson's Disease
Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39).
Time frame: Year 2
Quality of life in Parkinson's Disease
Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39).
Time frame: Year 5
Actimetry.
Actimetry data (energy expenditure, number of steps, sedentary time, total physical activity, etc.) will be obtained with the WGT3X-BT Actigraph inertial sensor unit.
Time frame: during 5 consecutive days after day 0
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Clermont-Ferrand